Pediatric lung transplantation

Current Treatment Options in Cardiovascular Medicine

Volumn 13, Issue 1, 2011, Pages 68-78

  Huddleston, Charles B ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; COTRIMOXAZOLE; CYCLOSPORIN; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; PENTAMIDINE; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ARTICLE; BACTERIAL INFECTION; BLOOD VESSEL SHUNT; BRONCHIOLITIS OBLITERANS; CANDIDIASIS; CHRONIC GRAFT REJECTION; CYSTIC FIBROSIS; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; GRAFT SURVIVAL; HEART ATRIUM FLUTTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; LIVING DONOR; LUNG DISEASE; LUNG FIBROSIS; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MUCOCUTANEOUS CANDIDIASIS; MYCOSIS; NERVE INJURY; PEDIATRIC SURGERY; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PROTEIN DEFECT; PULMONARY VASCULAR DISEASE; RESPIRATORY TRACT INFECTION; RETRANSPLANTATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VIRUS INFECTION;

EID: 79551531034     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-010-0105-6     Document Type: Article

References (47)

1. JD Cooper RJ Ginsberg M Goldberg 1986 The Toronto Lung Transplant Group. Unilateral transplantation for pulmonary fibrosis N Engl J Med 314 1140 1145 10.1056/NEJM198603063141030
2. P Aurora LB Edwards J Christie, et al. 2009 Registry of the International Society for Heart and Lung Transplantation: Twelfth official pediatric lung and heart/lung transplantation report-2009 J Heart Lung Transplant 28 1023 1030 10.1016/j.healun.2009.08.002 19782284 This registry report appears annually and provides a wealth of information regarding the current status and results of pediatric lung transplantation.
3. Cystic Fibrosis Foundation, Patient Registry 1999 Annual Report; Bethesda Maryland; September 2000.
4. E Kerem J Reisman M Corey GJ Canny H Levison 1992 Prediction of mortality in patients with cystic fibrosis N Engl J Med 326 1187 1191 1:STN:280:DyaK383ht1Cjsg%3D%3D 10.1056/NEJM199204303261804 1285737
5. W Robinson DA Waltz 2000 FEV1 as a guide to lung transplant referral in young patients with cystic fibrosis Pediatr Pulmonol 30 198 202 1:STN:280:DC%2BD3M%2FhtFekug%3D%3D 10.1002/1099-0496(200009)30:3<198::AID- PPUL3>3.0.CO;2-E 10973037
6. CE Milla WJ Warwick 1998 Risk of death in cystic fibrosis patients with severely compromised lung function Chest 113 1230 1234 1:STN:280: DyaK1c3lsFOgug%3D%3D 10.1378/chest.113.5.1230 9596299
7. TG Liou FR Adler DR Cox BC Cahill 2007 Lung transplantation and survival in children with cystic fibrosis N Engl J Med 357 2143 2152 1:CAS:528: DC%2BD2sXhtlGns7bE 10.1056/NEJMoa066359 18032764 (Pubitemid 350146109)
8. PA Corris JD Christie 2008 Update in transplantation 2007 Am J Respir Crit Care Med 177 1062 1067 10.1164/rccm.200802-247UP 18460461 (Pubitemid 351717563)
9. GE D'Alonzo RJ Barst SM Ayres, et al. 1991 Survival in patients with primary pulmonary hypertension: results from a national prospective registry Ann Int Med 115 343 349 1863023
10. K Dimopoulos R Inuzuka S Goletto G Glannakoulas L Swan SJ Sort MA Gatzoulis 2010 Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension Circulation 121 20 25 10.1161/CIRCULATIONAHA.109.883876 20026774
11. WE Hopkins LL Ochoe GW Richardson EP Trulock 1996 Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome J Heart Lung Transplant 15 100 105 1:STN:280: DyaK28vhslaqug%3D%3D 8820089
12. D Kerstein PS Levy DT Hsu AJ Hordof WM Gersony RJ Barst 1995 Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension Circulation 91 2028 2035 1:STN:280:DyaK2M3gt1yhtw%3D%3D 7534664
13. CML Canter CE Moller JH ND Bridges 1997 Hemodynamic data and survival in children with pulmonary hypertension J Am Coll Card 30 554 560 10.1016/S0735-1097(97)00155-1 (Pubitemid 27339338)
14. MK Pasque EP Trulock JD Cooper AN Triantafillou CB Huddleston M Rosenbloom S Sundaresan JL Cox GA Patterson 1995 Single lung transplantation of pulmonary hypertension. Single institution experience in 34 patients Circulation 92 2252 2258 1:STN:280:DyaK28%2Fhslejtw%3D%3D 7554209
15. E Osika MH Muller L Boccon-Gibod, et al. 1997 Idiopathic pulmonary fibrosis in infants Ped Pulm 23 49 54 1:STN:280:DyaK2s7oslOntw%3D%3D 10.1002/(SICI)1099-0496(199701)23:1<49::AID-PPUL6>3.0.CO;2-K (Pubitemid 27074132)
16. LK Jackson 1982 Idiopathic pulmonary fibrosis Clin Chest Med 3 579 1:STN:280:DyaL3s%2Fis1WisA%3D%3D 6751672
17. RJ Novick LW Stitt K Al-Kattan, et al. 1998 Pulmonary retransplantation: predictors of graft function and survival in 230 patients Ann Thorac Surg 65 227 234 1:STN:280:DyaK1c7hsFKmug%3D%3D 10.1016/S0003-4975(97)01191-0 9456123 (Pubitemid 28105898)
18. SC Sweet TL Spray CB Huddleston E Mendeloff CE Canter DT Balzer ND Bridges AH Cohen GB Mallory 1997 Pediatric lung transplantation at St. Louis Children's Hospital 1990-1995 Am J Resp Crit Care Med 155 1027 1035 1:STN:280:DyaK2s3jsF2isw%3D%3D 9116982
19. A Hamvas GB Mallory TL Spray, et al. 1997 Lung transplantation for treatment of infants with surfactant protein B deficiency J Ped 130 231 239 1:STN:280:DyaK2s7psVKrtQ%3D%3D 10.1016/S0022-3476(97)70348-2 (Pubitemid 27495158)
20. JP Couetil DP Houssin O Soubrane, et al. 1995 Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience J Thorac Cardiovasc Surg 110 1415 1422 1:STN:280:DyaK28%2FnsVeqsw%3D%3D 10.1016/S0022-5223(95)70064-1 7475193
21. BD Alexander EW Petzold LB Reller, et al. 2008 Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex Am J Transplant 8 1025 1030 1:STN:280:DC%2BD1c3lsFChsw%3D%3D 10.1111/j.1600-6143.2008.02186.x 18318775 (Pubitemid 351537763)
22. G Kurland 1996 Pediatric lung transplantation: indications and contraindications Semin Thorac Cardiovasc Surg 8 277 285 1:STN:280: DyaK2s%2FgtVCgtw%3D%3D 8843520
23. GL Bumgardner I Hardie RW Johnson, et al. 2001 Phase III Daclizumab Study Group. Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation Transplantation 72 839 845 1:CAS:528:DC%2BD3MXns1Kjtbg%3D 10.1097/00007890-200109150-00017 11571447
24. MV Brock MC Borja L Ferber, et al. 2001 Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab J Heart Lung Transplant 20 1282 1290 1:STN:280:DC%2BD3MnpvVeltQ%3D%3D 10.1016/S1053-2498(01)00356-4 11744411 (Pubitemid 34017313)
25. SM Stepkowski H Chen P Daloze BD Kahan 1991 Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney and small bowel transplantation in the rat Transplantation 51 22 26 1:CAS:528:DyaK3MXit1Sqt7s%3D 10.1097/00007890-199101000-00002 1987691
26. JD Cooper FG Pearson GA Patterson, et al. 1987 Technique of successful lung transplantation in humans J Thorac Cardiovasc Surg 93 173 181 1:STN:280:DyaL2s7hsVSqsw%3D%3D 3543506
27. J Ramirez GA Patterson 1992 Airway complications after lung transplantation Semin Thorac Cardiovasc Surg 4 147 153 1:STN:280: DyaK38zivFKhsg%3D%3D 1627694
28. PS Ro DM Bush SS Kramer, et al. 2001 Airway growth after pediatric lung transplantation J Heart Lung Transplant 20 619 624 1:STN:280: DC%2BD3Mzjs1GnsQ%3D%3D 10.1016/S1053-2498(01)00254-6 11404166 (Pubitemid 32515203)
29. PH Sheridan A Cheriyan J Doud SE Dornseif A Montoya J Houck ME Flisak JM Walsh ER Garrity 1995 Incidence of phrenic neuropathy after isolated lung transplantation J Heart Lung Transplant 14 684 691 7578176
30. CB Huddleston SC Sweet GB Mallory A Hamvas EN Mendeloff 1999 Lung transplantation in very young infants J Thorac Cardiovasc Surg 118 796 804 1:STN:280:DC%2BD3c%2Fgs1Sntg%3D%3D 10.1016/S0022-5223(99)70048-6 10534684 (Pubitemid 29511061)
31. SK Gandhi BI Bromberg GB Mallory CB Huddleston 1996 Atrial flutter-a newly recognized complication of pediatric lung transplantation J Thorac Cardiovasc Surg 112 984 991 1:STN:280:DyaK2s%2FislKjsA%3D%3D 10.1016/S0022-5223(96)70099-5 8873725 (Pubitemid 26339271)
32. SK Gandhi BI Bromberg RB Schuessler JP Boineau JL Cox CB Huddleston 1996 Left sided atrial flutter-characterization of a novel complication of pediatric lung transplantation in an acute canine model J Thorac Cardiovasc Surg 112 992 1001 1:STN:280:DyaK2s%2FislKjsQ%3D%3D 10.1016/S0022-5223(96)70100-9 8873726 (Pubitemid 26339272)
33. RC King OAR Binns F Rodriguz, et al. 2000 Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation Ann Thorac Surg 69 1681 1685 1:STN:280:DC%2BD3czkvV2qtw%3D%3D 10.1016/S0003-4975(00) 01425-9 10892906 (Pubitemid 30445505)
34. H Date AN Triantafillou EP Trulock, et al. 1996 Inhaled nitric oxide reduces human lung allograft dysfunction J Thorac Cardiovasc Surg 111 913 919 1:STN:280:DyaK283gt1eltA%3D%3D 10.1016/S0022-5223(96)70364-1 8622313 (Pubitemid 26146042)
35. Y Matsuzaki TK Waddell JD Puskas, et al. 1993 Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1 Am Rev Respir Dis 148 882 889 1:STN:280:DyaK2c%2FivVehtw%3D%3D 8214943
36. CB Huddleston SC Sweet AH Cohen EN Mendeloff GB Mallory 1998 Bronchiolitis obliterans after pediatric lung transplantation J Heart Lung Transplant 17 65
37. S Sundaresan EP Trulock T Mohanakumar JD Cooper GA Patterson 1995 Prevalence and outcome of bronchiolitis syndrome after lung transplantation Ann Thorac Surg 60 1341 1346 1:STN:280:DyaK28%2FmsVGhtA%3D%3D 10.1016/0003-4975(95) 00751-6 8526624
38. JD Cooper M Billlingham T Egan, et al. 1993 A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts J Heart Lung Transplant 12 713 716 1:STN:280: DyaK2c%2FmtVSgsA%3D%3D 8241207
39. RJ Novick LW Stitt K Al-Kattan, et al. 1998 Pulmonary retransplantation: predictors of graft function and survival in 230 patients Ann Thorac Surg 65 227 234 1:STN:280:DyaK1c7hsFKmug%3D%3D 10.1016/S0003-4975(97)01191-0 9456123 (Pubitemid 28105898)
40. RC Walker CV Paya WF Marshall, et al. 1995 Pretransplantation sero-negative Epstein-Barr virus status is the primary risk factor for post-transplantation lymphoproliferative disease in adult heart, lung and other solid organ transplantation J Heart Lung Transplant 14 214 221 1:STN:280:DyaK2M3pvVyjsA%3D%3D 7779838
41. C Knoop A Kentos M Remmelink, et al. 2006 Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission Clinical Transplant 20 179 187 10.1111/j.1399-0012.2005.00462.x
42. LJ Swinnen GM Mullen TJ Carr MR Costanzo RI Fisher 1995 Aggressive treatment for postcardiac transplant lymphoproliferation Blood 86 3333 3340 1:CAS:528:DyaK2MXovFahs7k%3D 7579436
43. EB Papadopoulos M Ladanyi D Emanuel, et al. 1994 Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation N Engl J Med 330 1185 1191 1:STN:280:DyaK2c7oslyisw%3D%3D 10.1056/NEJM199404283301703 8093146 (Pubitemid 24121987)
44. KH Rand RB Pollard TC Merigan 1987 Increased pulmonary superinfections-cardiac transplant recipients undergoing primary cytomegalovirus infection N Engl J Med 298 951 953 10.1056/NEJM197804272981705
45. M Cypel JC Yeung S Hirayama, et al. 2008 Technique for prolonged normothermic ex vivo lung perfusion J Heart Lung Transplant 27 1319 1325 10.1016/j.healun.2008.09.003 19059112
46. V Puri M Scavuzzo T Guthrie, et al. 2009 Lung transplantation and donation after cardiac death: a single center experience Ann Thorac Surg 88 1609 1614 10.1016/j.athoracsur.2009.06.039 19853120
47. NC De Oliveira S Osaki JD Maloney, et al. 2010 Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center J Thorac Cardiovasc Surg 139 1306 1315 10.1016/j.jtcvs.2010.02.004 20412963